Status:
COMPLETED
Human Papillomavirus Infection and Virus Genotyping in Uterine Cervix Cancer in Venezuela
Lead Sponsor:
Instituto Oncologico Luis Razetti
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Cervical Cancer
Eligibility:
FEMALE
Brief Summary
1. Hypothesis: If high risk genotypes of human papillomavirus (HPV) is the cause of cervical cancer worldwide, the genotypes associated with cervical cancer in Venezuela would be the same types fo...
Detailed Description
In Venezuela, cervical cancer is the second leading cause of cancer mortality in women. In developed countries, although it is not the first cause of cancer mortality, occupies a remarkable place in t...
Eligibility Criteria
Inclusion
- paraffin blocks of 329 patients with histologic diagnosis of CIN 2, CIN 3 or Stage I cervical cancer. -
Exclusion
- \-
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
329 Patients enrolled
Trial Details
Trial ID
NCT00937547
Start Date
November 1 2009
End Date
July 1 2011
Last Update
December 4 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Oncologico Luis razetti
Caracas, DF, Venezuela
2
Jorge Sanchez Lander
Caracas, Miranda, Venezuela, 1060